Andon Health Co., Ltd. (002432.SZ)
CNY 42.22
(-0.31%)
CNY 42.22
(-0.31%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.78 Billion CNY | 63.04% |
| 2022 | 1.7 Billion CNY | 55.92% |
| 2021 | 1.09 Billion CNY | 72.01% |
| 2020 | 636.09 Million CNY | 86.13% |
| 2019 | 341.74 Million CNY | -10.52% |
| 2018 | 381.91 Million CNY | -47.62% |
| 2017 | 729.06 Million CNY | -10.5% |
| 2016 | 814.57 Million CNY | 286.2% |
| 2015 | 210.92 Million CNY | -13.45% |
| 2014 | 243.68 Million CNY | 30.74% |
| 2013 | 186.39 Million CNY | 206.98% |
| 2012 | 60.71 Million CNY | -0.37% |
| 2011 | 60.94 Million CNY | 44.16% |
| 2010 | 42.27 Million CNY | -28.9% |
| 2009 | 59.45 Million CNY | -9.99% |
| 2008 | 66.05 Million CNY | 105.26% |
| 2007 | 32.18 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 4.44 Billion CNY | -1.18% |
| 2024 Q2 | 4.49 Billion CNY | 13.57% |
| 2024 Q1 | 3.95 Billion CNY | 42.33% |
| 2023 Q4 | 2.78 Billion CNY | 23.32% |
| 2023 Q1 | 1.54 Billion CNY | -9.29% |
| 2023 Q2 | 1.44 Billion CNY | -6.76% |
| 2023 FY | 2.78 Billion CNY | 63.04% |
| 2023 Q3 | 2.25 Billion CNY | 56.32% |
| 2022 FY | 1.7 Billion CNY | 55.92% |
| 2022 Q1 | 2.33 Billion CNY | 113.33% |
| 2022 Q4 | 1.7 Billion CNY | 7.3% |
| 2022 Q2 | 1.09 Billion CNY | -53.11% |
| 2022 Q3 | 1.58 Billion CNY | 45.27% |
| 2021 Q2 | 692.91 Million CNY | 23.66% |
| 2021 FY | 1.09 Billion CNY | 72.01% |
| 2021 Q3 | 610.16 Million CNY | -11.94% |
| 2021 Q4 | 1.09 Billion CNY | 79.32% |
| 2021 Q1 | 560.34 Million CNY | -11.91% |
| 2020 Q3 | 620.97 Million CNY | -7.66% |
| 2020 FY | 636.09 Million CNY | 86.13% |
| 2020 Q1 | 519.58 Million CNY | 52.04% |
| 2020 Q2 | 672.5 Million CNY | 29.43% |
| 2020 Q4 | 636.09 Million CNY | 2.43% |
| 2019 Q1 | 385.99 Million CNY | 1.07% |
| 2019 FY | 341.74 Million CNY | -10.52% |
| 2019 Q4 | 341.74 Million CNY | -5.38% |
| 2019 Q3 | 361.17 Million CNY | 7.81% |
| 2019 Q2 | 335 Million CNY | -13.21% |
| 2018 Q2 | 356.96 Million CNY | 5.02% |
| 2018 FY | 381.91 Million CNY | -47.62% |
| 2018 Q4 | 381.91 Million CNY | -13.96% |
| 2018 Q3 | 443.85 Million CNY | 24.34% |
| 2018 Q1 | 339.89 Million CNY | -53.38% |
| 2017 Q3 | 729.33 Million CNY | -13.46% |
| 2017 FY | 729.06 Million CNY | -10.5% |
| 2017 Q2 | 842.76 Million CNY | 0.53% |
| 2017 Q4 | 729.06 Million CNY | -0.04% |
| 2017 Q1 | 838.28 Million CNY | 2.91% |
| 2016 Q3 | 918.98 Million CNY | 431.63% |
| 2016 FY | 814.57 Million CNY | 286.2% |
| 2016 Q1 | 168.54 Million CNY | -20.09% |
| 2016 Q4 | 814.57 Million CNY | -11.36% |
| 2016 Q2 | 172.86 Million CNY | 2.56% |
| 2015 FY | 210.92 Million CNY | -13.45% |
| 2015 Q4 | 210.92 Million CNY | 16.94% |
| 2015 Q1 | 251.04 Million CNY | 3.02% |
| 2015 Q2 | 239.07 Million CNY | -4.77% |
| 2015 Q3 | 180.35 Million CNY | -24.56% |
| 2014 FY | 243.68 Million CNY | 30.74% |
| 2014 Q4 | 243.68 Million CNY | 31.78% |
| 2014 Q1 | 201.01 Million CNY | 7.84% |
| 2014 Q3 | 184.92 Million CNY | 17.32% |
| 2014 Q2 | 157.61 Million CNY | -21.59% |
| 2013 Q2 | 83.81 Million CNY | 126.59% |
| 2013 Q4 | 186.39 Million CNY | 40.1% |
| 2013 FY | 186.39 Million CNY | 206.98% |
| 2013 Q1 | 36.99 Million CNY | -39.08% |
| 2013 Q3 | 133.04 Million CNY | 58.73% |
| 2012 Q4 | 60.71 Million CNY | 9.81% |
| 2012 FY | 60.71 Million CNY | -0.37% |
| 2012 Q2 | 66.14 Million CNY | 83.11% |
| 2012 Q1 | 36.12 Million CNY | -40.72% |
| 2012 Q3 | 55.29 Million CNY | -16.42% |
| 2011 Q4 | 60.94 Million CNY | -3.56% |
| 2011 Q3 | 63.19 Million CNY | 13.81% |
| 2011 Q2 | 55.52 Million CNY | 145.99% |
| 2011 Q1 | 22.57 Million CNY | -46.6% |
| 2011 FY | 60.94 Million CNY | 44.16% |
| 2010 Q1 | 60.98 Million CNY | 2.57% |
| 2010 Q2 | 71.38 Million CNY | 17.05% |
| 2010 Q3 | 54.95 Million CNY | -23.01% |
| 2010 FY | 42.27 Million CNY | -28.9% |
| 2010 Q4 | 42.27 Million CNY | -23.08% |
| 2009 FY | 59.45 Million CNY | -9.99% |
| 2009 Q4 | 59.45 Million CNY | 0.0% |
| 2008 FY | 66.05 Million CNY | 105.26% |
| 2007 FY | 32.18 Million CNY | 0.0% |